» Articles » PMID: 19023410

Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda

Abstract

Over the past 30 years, Zaire and Sudan ebolaviruses have been responsible for large hemorrhagic fever (HF) outbreaks with case fatalities ranging from 53% to 90%, while a third species, Côte d'Ivoire ebolavirus, caused a single non-fatal HF case. In November 2007, HF cases were reported in Bundibugyo District, Western Uganda. Laboratory investigation of the initial 29 suspect-case blood specimens by classic methods (antigen capture, IgM and IgG ELISA) and a recently developed random-primed pyrosequencing approach quickly identified this to be an Ebola HF outbreak associated with a newly discovered ebolavirus species (Bundibugyo ebolavirus) distantly related to the Côte d'Ivoire ebolavirus found in western Africa. Due to the sequence divergence of this new virus relative to all previously recognized ebolaviruses, these findings have important implications for design of future diagnostic assays to monitor Ebola HF disease in humans and animals, and ongoing efforts to develop effective antivirals and vaccines.

Citing Articles

Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus Infection.

Bu F, Ye G, Morsheimer K, Mendoza A, Turner-Hubbard H, Herbst M PLoS Pathog. 2024; 20(12):e1012817.

PMID: 39715280 PMC: 11723632. DOI: 10.1371/journal.ppat.1012817.


Filovirus vaccines as a response paradigm for emerging infectious diseases.

Marzi A, Feldmann H NPJ Vaccines. 2024; 9(1):186.

PMID: 39394249 PMC: 11470150. DOI: 10.1038/s41541-024-00985-y.


A public, cross-reactive glycoprotein epitope confounds Ebola virus serology.

Kainulainen M, Harmon J, Karaaslan E, Kyondo J, Whitesell A, Twongyeirwe S J Med Virol. 2024; 96(10):e29946.

PMID: 39370872 PMC: 11874798. DOI: 10.1002/jmv.29946.


Metagenomic next generation sequencing of plasma RNA for diagnosis of unexplained, acute febrile illness in Uganda.

Kandathil A, Blair P, Lu J, Anantharam R, Kobba K, Robinson M PLoS Negl Trop Dis. 2024; 18(9):e0012451.

PMID: 39298515 PMC: 11460704. DOI: 10.1371/journal.pntd.0012451.


Non-Ebola Filoviruses: Potential Threats to Global Health Security.

Munyeku-Bazitama Y, Edidi-Atani F, Takada A Viruses. 2024; 16(8).

PMID: 39205153 PMC: 11359311. DOI: 10.3390/v16081179.


References
1.
Suzuki Y, Gojobori T . The origin and evolution of Ebola and Marburg viruses. Mol Biol Evol. 1997; 14(8):800-6. DOI: 10.1093/oxfordjournals.molbev.a025820. View

2.
Le Guenno B, Formenty P, Formentry P, Wyers M, Gounon P, Walker F . Isolation and partial characterisation of a new strain of Ebola virus. Lancet. 1995; 345(8960):1271-4. DOI: 10.1016/s0140-6736(95)90925-7. View

3.
Geisbert T, Daddario-DiCaprio K, Williams K, Geisbert J, Leung A, Feldmann F . Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates. J Virol. 2008; 82(11):5664-8. PMC: 2395203. DOI: 10.1128/JVI.00456-08. View

4.
Sanchez A, Ksiazek T, Rollin P, Miranda M, Trappier S, Khan A . Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis. 1999; 179 Suppl 1:S164-9. DOI: 10.1086/514282. View

5.
Ronquist F, Huelsenbeck J . MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics. 2003; 19(12):1572-4. DOI: 10.1093/bioinformatics/btg180. View